Wockhardt rose 2.33% to Rs 927 at 11:46 IST on BSE after UK health regulator completed inspection of the company's plant at Chikalthana in Maharashtra without issuing any critical observations on the facility.
The announcement was made during trading hours today, 29 September 2016.Meanwhile, the BSE Sensex was up 58.98 points, or 0.21%, to 28,351.79.
On BSE, so far 5.92 lakh shares were traded in the counter, compared with average daily volume of 3.17 lakh shares in the past one quarter. The stock hit a high of Rs 945 and a low of Rs 903 so far during the day. The stock hit a 52-week high of Rs 1,748.20 on 2 December 2015. The stock hit a 52-week low of Rs 706.35 on 12 February 2016. The stock had outperformed the market over the past 30 days till 28 September 2016, rising 9.16% compared with 0.18% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, falling 2.90% as against Sensex's 4.79% rise.
The large-cap company has equity capital of Rs 55.27 crore. Face value per share is Rs 5.
Wockhardt announced that inspection of the company's manufacturing unit at L-1, Chikalthana, Aurangabad, Maharashtra by UK Medicines and Healthcare products Regulatory Agency (MHRA) has since been completed without any critical observations and the approval status of the said unit continues.
On a consolidated basis, Wockhardt's net profit slumped 82.65% to Rs 15.89 crore on 6.57% decline in net sales to Rs 1064.01 crore in Q1 June 2016 over Q1 June 2015.
More From This Section
Wockhardt is a research based and technology intensive global pharmaceutical and biotechnology company.
Powered by Capital Market - Live News